Literature DB >> 7250640

Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats.

T Sawamura, S Kawasato, Y Shiozaki, Y Sameshima, H Nakada, Y Tashiro.   

Abstract

Acute liver injury was induced experimentally in rats by a single injection of a large amount of D-galactosamine. Hepatocellular damage was apparent from decrease of total serum proteins, marked release of transaminases into the circulation, precipitous decrease of total microsomal proteins, and intracellular enzymes such as cytochrome P450 and 5'-nucleotidase. In parallel with such hepatocellular damage, serum asialoglycoproteins accumulated markedly, reaching a maximum level 4 days after the injection and then decreased to the control level. In contrast to this increase, hepatic binding protein, a receptor in the liver which specifically recognizes asialoglycoproteins, decreased very much. At the same time, survival time of [125I]asialoorosomucoid intravenously administered into rats was much prolonged in inverse proportion to the decrease of the binding protein. From these results it was concluded that the decrease of the hepatic binding protein induced by galactosamine treatment is probably responsible for the marked accumulation of serum asialoglycoproteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7250640

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve?

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04       Impact factor: 2.374

2.  Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma.

Authors:  T Sawamura; S Kawasato; M Tsuda; Y Naitoh; Y Shiozaki; Y Sameshima
Journal:  Gastroenterol Jpn       Date:  1985-06

3.  A quantitative index measured on ⁹⁹mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease.

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04-12       Impact factor: 2.374

4.  Hepatocellular injury inhibits lectin-mediated tumor colonization into BALB/c-mice livers.

Authors:  J Beuth; H L Ko; M Steuer; G Pulverer
Journal:  Experientia       Date:  1993-07-05

5.  Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay.

Authors:  Y Satomura; N Sawabu; I Mouri; O Yamakawa; H Watanabe; Y Motoo; T Okai; T Ito; K Kaneda; H Okamoto
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

6.  99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro.

Authors:  I Virgolini; P Angelberger; C Müller; J O'Grady; H Sinzinger
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

7.  Serum levels of c-erbB-2 protein in digestive diseases.

Authors:  Y Motoo; N Sawabu; Y Yamaguchi; I Mouri; O Yamakawa; H Watanabe; H Ohta; T Okai; H Makino
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

8.  Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.

Authors:  I Virgolini; C Müller; W Klepetko; P Angelberger; H Bergmann; J O'Grady; H Sinzinger
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

9.  Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with (99m)Tc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice.

Authors:  Deliang Zhang; Zhide Guo; Pu Zhang; Yesen Li; Xinhui Su; Linyi You; Mengna Gao; Chang Liu; Hua Wu; Xianzhong Zhang
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

10.  Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis: A retrospective observational study.

Authors:  Kohei Kotani; Joji Kawabe; Shigeaki Higashiyama; Atsushi Yoshida; Etsushi Kawamura; Akihiro Tamori; Susumu Shiomi; Norifumi Kawada
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.